Stay updated on PROSTVAC Combo With Nivolumab in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the PROSTVAC Combo With Nivolumab in Prostate Cancer Clinical Trial page.

Latest updates to the PROSTVAC Combo With Nivolumab in Prostate Cancer Clinical Trial page
- Check3 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA general NIH notice about website changes and terminology appears above the unchanged 403 error page. The site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check30 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record details for NCT02933255. This blocks viewing the trial information and navigation on that page.SummaryDifference23%

- Check52 days agoChange DetectedThe page's revision tag was updated from v3.6.6 to v3.7.0, reflecting a small update to the page's metadata.SummaryDifference0.0%

- Check66 days agoChange DetectedA new Revision: v3.6.6 tag was added, and Prostate cancer, related topics, MedlinePlus Genetics, and Revision: v3.6.5 were removed.SummaryDifference0.2%

Stay in the know with updates to PROSTVAC Combo With Nivolumab in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PROSTVAC Combo With Nivolumab in Prostate Cancer Clinical Trial page.